dc.contributor.author | World Health Organization | |
dc.coverage.spatial | Geneva | EN |
dc.date.accessioned | 2015-03-24T16:14:17Z | |
dc.date.available | 2015-03-24T16:14:17Z | |
dc.date.issued | 2015 | |
dc.identifier.govdoc | WHO/HTM/TB/2015.01 | |
dc.identifier.uri | https://iris.who.int/handle/10665/158915 | |
dc.description | 79 p. | EN |
dc.description | Annex 4 of Guidelines published with ISBN 9789241548908 | EN |
dc.language.iso | en | EN |
dc.publisher | World Health Organization | EN |
dc.relation.uri | full guideline: http://apps.who.int/iris/handle/10665/136471 | |
dc.subject.mesh | Latent Tuberculosis | EN |
dc.subject.mesh | Immunologic Tests | EN |
dc.subject.mesh | Mycobacterium tuberculosis | EN |
dc.subject.mesh | Antitubercular Agents | EN |
dc.subject.mesh | Guideline | EN |
dc.title | Evidence to decision framework: appendix to the guidelines on the management of latent tuberculosis infection | EN |
dc.type | Technical documents | EN |